Search

Your search keyword '"Wisniewski T."' showing total 22 results

Search Constraints

Start Over You searched for: Author "Wisniewski T." Remove constraint Author: "Wisniewski T." Topic tau proteins Remove constraint Topic: tau proteins
22 results on '"Wisniewski T."'

Search Results

1. The relationship between anxiety and levels of Alzheimer's disease plasma biomarkers.

2. SMOC1 colocalizes with Alzheimer's disease neuropathology and delays Aβ aggregation.

3. Retrospective analysis of Braak stage- and APOE4 allele-dependent associations between MR spectroscopy and markers of tau and neurodegeneration in cognitively unimpaired elderly.

4. The influence of APOE ε4 on the pTau interactome in sporadic Alzheimer's disease.

5. Association between lower body temperature and increased tau pathology in cognitively normal older adults.

6. Plasma tau predicts cerebral vulnerability in aging.

7. Phosphorylated tau interactome in the human Alzheimer's disease brain.

8. Secernin-1 is a novel phosphorylated tau binding protein that accumulates in Alzheimer's disease and not in other tauopathies.

9. Anti-β-sheet conformation monoclonal antibody reduces tau and Aβ oligomer pathology in an Alzheimer's disease model.

10. Tau phosphorylation induced by severe closed head traumatic brain injury is linked to the cellular prion protein.

11. Aging-related tau astrogliopathy (ARTAG): harmonized evaluation strategy.

12. Greater specificity for cerebrospinal fluid P-tau231 over P-tau181 in the differentiation of healthy controls from Alzheimer's disease.

13. PART, a distinct tauopathy, different from classical sporadic Alzheimer disease.

14. Immunotherapeutic approaches for Alzheimer's disease.

15. Amyloid β and Tau Alzheimer's disease related pathology is reduced by Toll-like receptor 9 stimulation.

16. Blocking the apolipoprotein E/amyloid β interaction in triple transgenic mice ameliorates Alzheimer's disease related amyloid β and tau pathology.

17. Tau-based therapeutic approaches for Alzheimer's disease - a mini-review.

18. Immunomodulation targeting of both Aβ and tau pathological conformers ameliorates Alzheimer's disease pathology in TgSwDI and 3xTg mouse models.

19. Link between DYRK1A overexpression and several-fold enhancement of neurofibrillary degeneration with 3-repeat tau protein in Down syndrome.

20. Vaccination as a therapeutic approach to Alzheimer's disease.

21. Longitudinal cerebrospinal fluid tau load increases in mild cognitive impairment.

22. New insights into the genetic etiology of Alzheimer's disease and related dementias

Catalog

Books, media, physical & digital resources